These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28501823)

  • 21. The Cerebellum in Frontotemporal Dementia: a Meta-Analysis of Neuroimaging Studies.
    Chen Y; Kumfor F; Landin-Romero R; Irish M; Piguet O
    Neuropsychol Rev; 2019 Dec; 29(4):450-464. PubMed ID: 31428914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.
    Erkkinen MG; Kim MO; Geschwind MD
    Cold Spring Harb Perspect Biol; 2018 Apr; 10(4):. PubMed ID: 28716886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroimaging patterns along the ALS-FTD spectrum: a multiparametric imaging study.
    Omer T; Finegan E; Hutchinson S; Doherty M; Vajda A; McLaughlin RL; Pender N; Hardiman O; Bede P
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):611-623. PubMed ID: 28562080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral arterial endothelial dysfunction of neurodegenerative diseases.
    Fukui Y; Hishikawa N; Shang J; Sato K; Nakano Y; Morihara R; Ohta Y; Yamashita T; Abe K
    J Neurol Sci; 2016 Jul; 366():94-99. PubMed ID: 27288784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural cerebellar correlates of cognitive functions in spinocerebellar ataxia type 2.
    Olivito G; Lupo M; Iacobacci C; Clausi S; Romano S; Masciullo M; Molinari M; Cercignani M; Bozzali M; Leggio M
    J Neurol; 2018 Mar; 265(3):597-606. PubMed ID: 29356974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy.
    Tse NY; Chen Y; Irish M; Cordato NJ; Landin-Romero R; Hodges JR; Piguet O; Ahmed RM
    Brain Commun; 2020; 2(2):fcaa194. PubMed ID: 33381758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O; Gorges M; Müller HP; Pinkhardt EH; Ludolph AC; Huppertz HJ; Kassubek J
    Neurodegener Dis; 2017; 17(4-5):117-126. PubMed ID: 28268209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review.
    Last N; Tufts E; Auger LE
    J Alzheimers Dis; 2017; 56(1):275-286. PubMed ID: 27983555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar dentate nucleus in progressive supranuclear palsy.
    Sawa N; Kataoka H; Kiriyama T; Izumi T; Taoka T; Kichikawa K; Ueno S
    Clin Neurol Neurosurg; 2014 Mar; 118():32-6. PubMed ID: 24529226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging in aging and neurologic diseases.
    Risacher SL; Saykin AJ
    Handb Clin Neurol; 2019; 167():191-227. PubMed ID: 31753134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional microstructural damage and patterns of eye movement impairment: a DTI and video-oculography study in neurodegenerative parkinsonian syndromes.
    Gorges M; Maier MN; Rosskopf J; Vintonyak O; Pinkhardt EH; Ludolph AC; Müller HP; Kassubek J
    J Neurol; 2017 Sep; 264(9):1919-1928. PubMed ID: 28762086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volumetric analysis of the cerebellum in patients with progressive supranuclear palsy.
    Lee Y; Lee DK; Lee JM; Chung SJ; Lee JJ; Sohn YH; Lee PH
    Eur J Neurol; 2017 Jan; 24(1):212-218. PubMed ID: 27747983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral and cerebellar grey matter atrophy in Friedreich ataxia: the IMAGE-FRDA study.
    Selvadurai LP; Harding IH; Corben LA; Stagnitti MR; Storey E; Egan GF; Delatycki MB; Georgiou-Karistianis N
    J Neurol; 2016 Nov; 263(11):2215-2223. PubMed ID: 27522354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.